Patient data, including age, gender, clinical stage at time of experiment (Binet), IGHV mutational status, FISH results, ZAP70 expression, and experiments performed with this sample
| Number . | Age (y) . | Gender . | Binet . | IGHV . | FISH . | ZAP70 . | Experiments performed . |
|---|---|---|---|---|---|---|---|
| 34 | 46 | m | A | UM | 12q+ | Positive | Survival; CCL2 |
| 39 | 59 | m | C | UM | 13q− | nd | Survival; CCL2 |
| 101 | 59 | f | A | M | 13q−; 14q− | Negative | Survival; CCL2; IL-10; HLA-DR |
| 102 | 49 | m | nd | nd | nd | nd | CD54 |
| 111 | 66 | m | A | UM | 11q−; 12p+; t(14q) | Positive | Survival; CCL2; IL-10; HLA-DR |
| 113 | 76 | m | nd | M | 13q− | Negative | CD54 |
| 114 | 67 | m | A | UM | 13q− | nd | CD54 |
| 115 | 62 | f | A | M | 13q− | nd | Survival; CCL2; IL-10; HLA-DR |
| 122 | 51 | m | B | M V3-53 | 13q− | Negative | Survival; CCL2; IL-10 |
| 123 | 76 | m | C | UM V1-69 | 11q−; 13q−; 14q− | Negative | Survival; CCL2; IL-10 |
| 124 | 49 | m | A | M | Normal | Negative | Survival; CCL2; IL-10 |
| 127 | 53 | m | A | M | 13q− | Negative | CD54 |
| 138 | 44 | m | B | UM | 13q− | Negative | CD54 |
| 139 | 60 | f | A | M | 13q−; 14q− | Negative | CD54 |
| 149 | 65 | f | A | M | Normal | Negative | Survival; CCL2; IL-10 |
| 150 | 61 | m | A | M | 13q- | Negative | CD54 |
| 151 | 66 | f | A | M | 13q− | Negative | Survival; CCL2 |
| 155 | 42 | m | A | M | Normal | Negative | Survival; CCL2 |
| 157 | 77 | m | A | M | 13q− | Negative | Survival; CCL2; IL-10 |
| 178 | 54 | m | nd | nd | Tris12, 13q−; 14q−; 17p− | nd | qRT-PCR |
| 180 | 49 | m | nd | nd | 13q bidel | nd | Survival; p-STAT1 |
| 194 | 63 | f | B | M | 13q− | nd | qRT-PCR |
| 195 | 62 | f | A | UM | Tris12; 17p− | Positive | Migration |
| 196 | 71 | m | A | M | 13q− | Negative | Survival; migration; p-STAT1 |
| 197 | 72 | f | nd | nd | Tris12 | nd | Survival; p-STAT1 |
| 199 | 79 | f | nd | nd | 17p−; 14q− | nd | Migration |
| 212 | 42 | m | A | M | Normal | Negative | qRT-PCR; p-STAT1 |
| 222 | 62 | m | C | M | 13q− | Negative | qRT-PCR |
| 229 | 61 | m | B | M | 13q− | nd | p-STAT1 |
| 238 | 60 | f | A | M | 13q−; 14q− | Negative | p-STAT1 |
| 245 | 62 | m | B | M | Normal | Negative | qRT-PCR; p-STAT1 |
| 260 | 43 | m | nd | M | Normal | nd | p-STAT1 |
| 263 | 60 | f | A | M | 13q−; 14q− | Negative | p-STAT1 |
| 264 | 53 | m | A | UM | nd | nd | p-STAT1 |
| 296 | 53 | m | B | M | 13q− | Negative | Migration |
| 299 | 55 | m | C | M | 13q− | Negative | p-STAT1 |
| 300 | 64 | f | C | M | 13q− | nd | Migration |
| Number . | Age (y) . | Gender . | Binet . | IGHV . | FISH . | ZAP70 . | Experiments performed . |
|---|---|---|---|---|---|---|---|
| 34 | 46 | m | A | UM | 12q+ | Positive | Survival; CCL2 |
| 39 | 59 | m | C | UM | 13q− | nd | Survival; CCL2 |
| 101 | 59 | f | A | M | 13q−; 14q− | Negative | Survival; CCL2; IL-10; HLA-DR |
| 102 | 49 | m | nd | nd | nd | nd | CD54 |
| 111 | 66 | m | A | UM | 11q−; 12p+; t(14q) | Positive | Survival; CCL2; IL-10; HLA-DR |
| 113 | 76 | m | nd | M | 13q− | Negative | CD54 |
| 114 | 67 | m | A | UM | 13q− | nd | CD54 |
| 115 | 62 | f | A | M | 13q− | nd | Survival; CCL2; IL-10; HLA-DR |
| 122 | 51 | m | B | M V3-53 | 13q− | Negative | Survival; CCL2; IL-10 |
| 123 | 76 | m | C | UM V1-69 | 11q−; 13q−; 14q− | Negative | Survival; CCL2; IL-10 |
| 124 | 49 | m | A | M | Normal | Negative | Survival; CCL2; IL-10 |
| 127 | 53 | m | A | M | 13q− | Negative | CD54 |
| 138 | 44 | m | B | UM | 13q− | Negative | CD54 |
| 139 | 60 | f | A | M | 13q−; 14q− | Negative | CD54 |
| 149 | 65 | f | A | M | Normal | Negative | Survival; CCL2; IL-10 |
| 150 | 61 | m | A | M | 13q- | Negative | CD54 |
| 151 | 66 | f | A | M | 13q− | Negative | Survival; CCL2 |
| 155 | 42 | m | A | M | Normal | Negative | Survival; CCL2 |
| 157 | 77 | m | A | M | 13q− | Negative | Survival; CCL2; IL-10 |
| 178 | 54 | m | nd | nd | Tris12, 13q−; 14q−; 17p− | nd | qRT-PCR |
| 180 | 49 | m | nd | nd | 13q bidel | nd | Survival; p-STAT1 |
| 194 | 63 | f | B | M | 13q− | nd | qRT-PCR |
| 195 | 62 | f | A | UM | Tris12; 17p− | Positive | Migration |
| 196 | 71 | m | A | M | 13q− | Negative | Survival; migration; p-STAT1 |
| 197 | 72 | f | nd | nd | Tris12 | nd | Survival; p-STAT1 |
| 199 | 79 | f | nd | nd | 17p−; 14q− | nd | Migration |
| 212 | 42 | m | A | M | Normal | Negative | qRT-PCR; p-STAT1 |
| 222 | 62 | m | C | M | 13q− | Negative | qRT-PCR |
| 229 | 61 | m | B | M | 13q− | nd | p-STAT1 |
| 238 | 60 | f | A | M | 13q−; 14q− | Negative | p-STAT1 |
| 245 | 62 | m | B | M | Normal | Negative | qRT-PCR; p-STAT1 |
| 260 | 43 | m | nd | M | Normal | nd | p-STAT1 |
| 263 | 60 | f | A | M | 13q−; 14q− | Negative | p-STAT1 |
| 264 | 53 | m | A | UM | nd | nd | p-STAT1 |
| 296 | 53 | m | B | M | 13q− | Negative | Migration |
| 299 | 55 | m | C | M | 13q− | Negative | p-STAT1 |
| 300 | 64 | f | C | M | 13q− | nd | Migration |
f, female; FISH, fluorescence in situ hybridization; m, male; M, mutated IGHV; nd, not determined; qRT-PCR, quantitative reverse-transcription PCR; UM, unmutated.